The outcome of colposcopy in women attending with persistent postcoital bleeding and negative HPV-DNA test Postcoital bleeding and negative HPV-DNA test

Main Article Content

Mehmet Bayrak
Hakan Ozan


Objective: Women with postcoital bleeding (PCB) are recommended to be evaluated by colposcopy even if cytology is negative. Human papillomavirus (HPV) testing increases the detection of cervical intraepithelial neoplasia or worse compared to the Pap smear test. We aimed to determine the incidence of cervical pathology among women with persistent PCB with a negative Pap smear or HPV-DNA test. Our study, therefore, questions the place of HPV DNA test in women with PCB.

Material and Methods: The clinical data of 212 women with persistent PCB and negative cytology or negative HPV DNA test referred to colposcopy, between January 2010 and June 2019, were retrospectively evaluated.

Results: Among the 212 PCB patients, 161 (75.9%) were cytology negative and 51 (24.1%) were HPV DNA test (n=40) or co-test (n=11)  (negative for HPV DNA test and cytology) negative. There were no cases of invasive cancer. The women referred with negative cytology were more likely than those with negative HPV DNA to have CIN (21/161 (13%),  1/51 (1.9%) p=0.042. Seven women (4.3%) were diagnosed with high-grade cervical dysplasia in the negative cytology group. None of the patients in the HPV DNA negative group was diagnosed with high-grade cervical dysplasia.

Conclusion: Our data show that a normal Pap smear cytology in women with PCB does not rule out the possibility of  HSIL. HPV DNA testing is a useful triage test to determine if colposcopy referral is required in the context of post-coital bleeding with negative smear test.


Download data is not yet available.

Article Details

How to Cite
Bayrak, M., & Ozan, H. (2021). The outcome of colposcopy in women attending with persistent postcoital bleeding and negative HPV-DNA test. Medical Science and Discovery, 8(2), 97-100.
Research Article
Author Biography

Hakan Ozan, Bursa Uludag University

Department of Gynecologic Oncology,  Uludag University Hospital


1.Gulumser, C., Tuncer, A., Kuscu, E., & Ayhan, A. (2015). Is colposcopic evaluation necessary in all women with postcoital bleeding?. European Journal of Obstetrics & Gynecology and Reproductive Biology, 193, 83-87.
2. Alfhaily, F., & Ewies, A. A. (2009). Postcoital bleeding: a study of the current practice amongst consultants in the United Kingdom. European Journal of Obstetrics & Gynecology and Reproductive Biology, 144(1), 72-75.
3. Alfhaily, F., & Ewies, A. A. A. (2010). Managing women with post-coital bleeding: A prospective observational non-comparative study. Journal of Obstetrics and Gynaecology, 30(2), 190-194.
4. Khattab, A. F., Ewies, A. A., Appleby, D., & Cruickshank, D. J. (2005). The outcome of referral with postcoital bleeding (PCB). Journal of obstetrics and gynaecology, 25(3), 279-282.
5. Song, T., Seong, S. J., Lee, S. K., Kim, B. R., Ju, W., Kim, K. H., ... & Kim, T. J. (2020). Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer. Journal of Obstetrics and Gynaecology, 40(2), 240-246
6. Naucler, P., Ryd, W., Törnberg, S., Strand, A., Wadell, G., Elfgren, K., ... & Hagmar, B. (2009). Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening. Journal of the National Cancer Institute, 101(2), 88-99.
7. Godfrey, M. A., Nikolopoulos, M., Povolotskaya, N., Chenoy, R., & Wuntakal, R. (2019). Post-coital bleeding: What is the incidence of significant gynaecological pathology in women referred for colposcopy?. Sexual & Reproductive healthcare, 22, 100462.
8. Darragh, T. M., Colgan, T. J., Cox, J. T., Heller, D. S., Henry, M. R., Luff, R. D., ... & Wilkinson, E. J. (2012). The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Archives of pathology & laboratory medicine, 136(10), 1266-129
9. Jha, S., & Sabharwal, S. (2002). Outcome of colposcopy in women presenting with postcoital bleeding and negative or no cytology-results of a 1-year audit. Journal of Obstetrics and Gynaecology, 22(3), 299-301
10. Sahu, B., Latheef, R., & Magd, S. A. (2007). Prevalence of pathology in women attending colposcopy for postcoital bleeding with negative cytology. Archives of Gynecology and Obstetrics, 276(5), 471-473.
11. Koliopoulos, G., Nyaga, V. N., Santesso, N., Bryant, A., Martin‐Hirsch, P. P., Mustafa, R. A., ... & Arbyn, M. (2017). Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane database of systematic reviews, (8).
12. Rosenthal, A. N., Panoskaltsis, T., Smith, T., & Soutter, W. P. (2001). The frequency of significant pathology in women attending a general gynaecological service for postcoital bleeding. BJOG: An International Journal of Obstetrics & Gynaecology, 108(1), 103-106.
13. Perkins, R. B., Guido, R. S., Castle, P. E., Chelmow, D., Einstein, M. H., Garcia, F., ... & Saraiya, M. (2020). 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. Journal of lower genital tract disease, 24(2), 102.
14. Tan, J. H., Jayasinghe, Y. L., Osinski, M. J., Brotherton, J. M., & Wrede, C. D. H. (2020). Recurrent post‐coital bleeding: Should colposcopy still be mandatory?. Australian and New Zealand Journal of Obstetrics and Gynaecology.

DB Error: Unknown column 'Array' in 'where clause'